<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:18:21" record="41121" source="Espacenet">
	<entities>
		<entity ref="Patent41121" type="Patent">
			<semanticIdentifier>brcris::e74120191cfa6e75b732b9072fcb8e13</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013002260A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102013002260</semanticIdentifier>
			<semanticIdentifier>docdb::BR102013002260A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20131002260</semanticIdentifier>
			<semanticIdentifier>original::BRBR 10 2013 002260-8</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102013002260"/>
			<field name="identifier.lattes" value="1824470158154822"/>
			<field name="identifier.espacenet" value="102013002260"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="SÍNTESE DE NOVOS 1,2,3-TRIAZÓIS DERIVADOS DA BERGENINA, COMPOSIÇÕES E USO COMO INIBIDORES DAS ENZIMAS GLICOSIDASES"/>
			<field name="title.lattes" value="SÍNTESE DE NOVOS 1,2,3-TRIAZÓIS DERIVADOS DA BERGENINA, COMPOSIÇÕES E USO COMO INIBIDORES DAS ENZIMAS GLICOSIDASES"/>
			<field name="depositDate" value="2013-01-30"/>
			<field name="publicationDate" value="2014-09-09"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="CARLOS ROLAND KAISER"/>
			<field name="inventor" value="FLORIANO PAES SILVA JUNIOR"/>
			<field name="inventor" value="LUIS GABRIEL VALDIVIESO GELVES"/>
			<field name="inventor" value="MARIA ROBERTO SENGER"/>
			<field name="inventor" value="SABRINA BAPTISTA FERREIRA"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DO RIO DE JANEIRO-UFRJ"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="C07D249/04AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="D"/>
				<field name="group" value="249"/>
				<field name="subgroup" value="04AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/4192AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="4192AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P3/04AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="3"/>
				<field name="subgroup" value="04AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P3/10AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="3"/>
				<field name="subgroup" value="10AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P37/04AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="37"/>
				<field name="subgroup" value="04AI"/>
			</field>
			<field name="abstract.espacenet" value="SÍNTESE DE NOVOS 1,2,3-TRIAZÓIS DERIVADOS DA BERGENINA, COMPOSIÇÕES E USO COMO INIBIDORES DAS ENZIMAS GLICOSIDASES. A presente invenção descreve compostos triazólicos inibidores de alfa-glicosidades e seus processos de síntese. Os compostos da presente invenção apresenta compreendem o grupo 1,2-3-triazóis contendo a porção bergenina com atividade inibitória de &lt;244&gt;-glicosidases e seus derivados compreendendo a fórmula geral (I) e (II). Em outro aspecto da presente invenção, os compostos podem ser utilizados na obtenção de composições farmacêuticas com atividades antiproliferativa, antiobesidade, imunoestimulantes, e antidiabetes."/>
			<field name="originatesFrom" value="51483821"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013002260"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102013002260"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102013002260"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20131002260"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR 10 2013 002260-8"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person27983" type="Person">
			<semanticIdentifier>lattes::1824470158154822</semanticIdentifier>
			<field name="identifier.lattes" value="1824470158154822"/>
			<field name="name" value="Sabrina Baptista Ferreira"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent41121" toEntityRef="Person27983" type="Inventor"/>
	</relations>
</entity-relation-data>
